Plasmodium fragile: inhibition of cultures by serum from rhesus monkeys immunized with homologous parasites.
Rhesus monkeys, Macaca mulatta, that had previously been immunized with the Nilgiri strain of Plasmodium fragile grown in culture, together with control monkeys with and without inoculation of Freund's adjuvant, were challenged with cultured parasites. After treatment with chloroquine, the monkeys were rechallenged. Serum specimens from three immunized monkeys caused a specific, dose-dependent inhibition of parasite growth in culture. Fifty percent inhibition of in vitro growth was obtained using 5% immune serum combined with 10% normal rhesus serum. The specific inhibitory component of immune serum was shown to be IgG antibody. Results of the study demonstrated that there is good correlation between the inhibitory activity of immune serum, parasite growth in vitro, the in vivo response to challenge, and the indirect fluorescent antibody titer.
D000818:Animals; D000918:Antibody Specificity; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology; D004912:Erythrocytes / Q000469:parasitology; D007106:Immune Sera / Q000276:immunology*; D007114:Immunization; D007074:Immunoglobulin G / Q000276:immunology; D008253:Macaca mulatta; D008288:Malaria / Q000276:immunology* / Q000469:parasitology; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology*; D013045:Species Specificity
D007106:Immune Sera; D007074:Immunoglobulin G; D002738:Chloroquine